Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VISTA: Visudyne + Kenalog in AMD
NCT00140803Phase 2Completed
- Sponsor
- Manhattan Eye, Ear and Throat Hospital
- Start
- Oct 2003
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of triamcinolone in age-related macular degeneration (AMD), sponsored by Manhattan Eye, Ear and Throat Hospital. Started Oct 2003; status: completed.
02
Drugs
triamcinolone
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT00140803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00140803.